reports
Berkeley Lights to Participate at the 27th European Society for Animal...
Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® Platform EMERYVILLE, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 27th Annual European Society for Animal Cell Technology (ESCAT), being held from June 26 - 29, 2022 at the Lisbon Congress Centre in Lisbon, Portugal. This year’s conference, with the motto, “Adv...
Berkeley Lights Reports First Quarter 2022 Financial Results
Berkeley Lights Reports First Quarter 2022 Financial Results EMERYVILLE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Delivered total revenue of $20.2 million for the first quarter of 2022, representing growth of 8.5% year over yearSigned a strategic partnership agreement with Vestaron to develop pesticidal peptides using the Company’s Beacon® platform and proprietary high-throughput, functional screening service Released an upgrade ...
Berkeley Lights to Participate in the 18th Annual PEGS Boston Conferen...
Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo Company’s latest data to be presented on “Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification” EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 18th Annual PEGS Boston Conference, a protein engineering and cell therapy summit, being held virtually and in person from May 2-6, 2022 at the Hynes Convention Center. Berkeley Lights’ participation this year...
Berkeley Lights to Report First Quarter 2022 Financial Results on May ...
Berkeley Lights to Report First Quarter 2022 Financial Results on May 9, 2022 EMERYVILLE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the first quarter 2022 after market on Monday, May 9, 2022. Company management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of the Company’s website at The webcast will be a...
Berkeley Lights Announces Appointment of Lucas S. Vitale as Chief Huma...
Berkeley Lights Announces Appointment of Lucas S. Vitale as Chief Human Resources Officer EMERYVILLE, Calif., April 13, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the appointment of Lucas Vitale to the newly created role of Chief Human Resources Officer (“CHRO”), effective immediately. Vitale will lead Berkeley Lights' Human Resources function. He will report directly to the Company’s Chief Executive Officer (CEO), Dr. Siddhartha Kadia. As Berkeley Lights’ newly appointed CEO, Dr. Kadia is focused on the further development of...
Berkeley Lights and Vestaron Announce Partnership to Develop Pesticida...
Berkeley Lights and Vestaron Announce Partnership to Develop Pesticidal Peptides Utilizing Proprietary High-Throughput, Functional Screening Service EMERYVILLE, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Vestaron Corporation, the leader in peptide-based crop protection, announced a strategic partnership to advance the development of pesticidal peptides as Active Ingredients (AIs) to improve the safety and efficacy of crop protection solutions for the global food supply. In this partnership, Vestaron will use Berke...
BERKELEY LIGHTS sees an upgrade to Slightly Negative thanks to a bette...
The independent financial analyst theScreener just awarded an improved star rating to BERKELEY LIGHTS (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 1 out of 4 possible stars. Given its market behaviour as risky, theScreener considers that these elements allowing slightly upgrading its general evaluation to Slightly Negative; the title, however, remains unattractive. As of the analysis date March 18, ...
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief...
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia as Chief Executive Officer EMERYVILLE, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI) (“Berkeley Lights” or the “Company”) a leader in digital cell biology, today announced it has appointed Dr. Siddhartha Kadia as its new chief executive officer (CEO), effective immediately. Dr. Kadia succeeds Eric D. Hobbs, Ph.D., as part of the previously announced leadership transition. Dr. Kadia will remain a member of the Berkeley Lights Board of Directors. Dr. Kadia is an accomplished executive, bringing...
Berkeley Lights to Showcase its Optofluidic Discovery Technology at 20...
Berkeley Lights to Showcase its Optofluidic Discovery Technology at 2022 Festival of Biologics Conference EMERYVILLE, Calif., March 04, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Festival of Biologics meeting, being held from March 9-11, 2022, at the Marriott Marquis San Diego. The Festival of Biologics brings together pharma, biotech and academic and research institutes, as well as their partners across the value chain in the areas of antibodies, immunotherapy and biosimilars. Berkeley...
Berkeley Lights Releases Upgrade to its Software Suite for Beacon® and...
Berkeley Lights Releases Upgrade to its Software Suite for Beacon® and Lightning™ Platforms Scientific researchers can now more easily assess cell and assay quality in real-time by selecting the best individual cells for live export EMERYVILLE, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI) a leader in digital cell biology, today released an upgrade to its Software Suite including enhancements to Cell Analysis Suite (CAS™), Image Analyzer, and Assay Analyzer software for the Berkeley Lights Beacon and Lightning Systems. Existing and new features will deli...
Berkeley Lights to Participate in Cowen 42nd Annual Health Care Confer...
Berkeley Lights to Participate in Cowen 42nd Annual Health Care Conference EMERYVILLE, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the Company will participate in the Cowen 42nd Annual Health Care Conference, taking place virtually March 7-9, 2022. Eric Hobbs, Ph.D., chief executive officer of Berkeley Lights, will participate on the Synthetic Biology Enabling Technologies Panel on Monday, March 7 at 10:30 a.m. – 11:30 a.m. Eastern Time. Berkeley Lights management will present in a fireside chat on Tuesd...
Berkeley Lights Reports Fourth Quarter and Full Year 2021 Financial Re...
Berkeley Lights Reports Fourth Quarter and Full Year 2021 Financial Results Reports full year 2021 revenue of $85.4 million, above pre-announced preliminary range Reiterates 2022 revenue outlook EMERYVILLE, Calif., Feb. 24, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today reported financial results for the fourth quarter and full year ended December 31, 2021. Recent Highlights Achieved revenue of $85.4 million for the full year 2021, including $23.2 million for the fourth quarter, representing growth of 33% and 7% over the prior ye...
Berkeley Lights to Report Fourth Quarter and Full Year 2021 Financial ...
Berkeley Lights to Report Fourth Quarter and Full Year 2021 Financial Results on February 24, 2022 EMERYVILLE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that the Company will be reporting financial results for the fourth quarter and full year 2021 before market open on Thursday, February 24, 2022. Company management will be webcasting a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “Investors” section of th...
Berkeley Lights to Participate in BTIG MedTech, Digital Health, Life S...
Berkeley Lights to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference EMERYVILLE, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the Company will participate in the upcoming BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference being held virtually from February 15 - 17, 2022. Berkeley Lights management is scheduled to present on Wednesday, February 16 at 9:00 a.m. Pacific Time / 12:00 p.m. Eastern Time. BTIG hosted events are intended for prospective...
Berkeley Lights and Aanika Biosciences Announce Partnership to Improve...
Berkeley Lights and Aanika Biosciences Announce Partnership to Improve Food Safety by Commercializing Antimicrobial Peptides through Proprietary High-Throughput, Functional Screening Service EMERYVILLE, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Aanika Biosciences, a growing biotech start-up using edible microbial tags to improve food safety, today announced a strategic partnership that will enable faster identification of outbreak sources, reduce incidents of fresh produce contamination and minimize the impact of f...
Berkeley Lights Announces CEO Transition and Preliminary Full Year 202...
Berkeley Lights Announces CEO Transition and Preliminary Full Year 2021 Financial Update Company Provides 2022 Revenue Growth Outlook EMERYVILLE, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., (Nasdaq: BLI), (“BLI” or “the Company”), a leader in digital cell biology, today announced that Eric D. Hobbs, Ph.D. will transition from his role as chief executive officer (CEO) and member of the board of directors to president of the Antibody Therapeutics business line. The Company is initiating a search for a new CEO as it continues to execute on its business strategy, includ...
Berkeley Lights to Participate in the 40th Annual J.P. Morgan Healthca...
Berkeley Lights to Participate in the 40th Annual J.P. Morgan Healthcare Conference EMERYVILLE, Calif., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the Company will be participating virtually in the upcoming 40th Annual J.P. Morgan Healthcare Conference. Berkeley Lights management is scheduled to present on Tuesday, January 11 at 12:45 p.m. Pacific Time / 3:45 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at Ab...
Dr. Jessica Hopfield Appointed to Berkeley Lights Board of Directors
Dr. Jessica Hopfield Appointed to Berkeley Lights Board of Directors Addition of Experienced Independent Director with Accomplished Business Record Underscores Berkeley Lights Board of Directors’ Commitment to Delivering Value for Shareholders EMERYVILLE, Calif., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced the appointment of Jessica Hopfield, Ph.D. to the Berkeley Lights’ Board of Directors as an independent director, effective December 15, 2021. "Dr. Hopfield is a respected and accomplished industry veteran,...
Berkeley Lights to Showcase its Optofluidic Discovery Technology at 20...
Berkeley Lights to Showcase its Optofluidic Discovery Technology at 2021 Antibody Engineering & Therapeutics Conference Genovac, a top contract research and manufacturing organization, to report new single B-cell service offerings and GPCR campaign results achieved from the Berkeley Lights Beacon® Optofluidic System for antibody discovery EMERYVILLE, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the upcoming Antibody Engineering & Therapeutics (AE&T) meeting, being held virtually and i...
Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofl...
Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers and develops antibodies for immunotechnology therapeutics and research, today announced the acquisition of the Berkeley Lights Beacon® system via a TechAccess subscription to help further its mission of helping its customers in the generation and validation of novel therapeutic antibodies again...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.